Lancaster, CANCT07089836Now EnrollingIRB Ready

Treponema Pallidum Clinical Trial in Lancaster, CA

Access cutting-edge treponema pallidum treatment through this clinical trial at a research site in Lancaster. Study-provided care at no cost to qualified participants.

Sponsored by American Laboratory Products Company

Quick Self-Assessment

See if you qualify for this Lancaster location

Preparing your pre-screening questions…

Expert Care in Lancaster

Access treponema pallidum specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related treponema pallidum treatment provided free

Apply for This Lancaster Location

Check if you qualify for this treponema pallidum clinical trial in Lancaster, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lancaster

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lancaster site if eligible
  4. 4Begin participation

About This Treponema Pallidum Study in Lancaster

This study will evaluate the clinical performance of two investigational diagnostic kits developed by ALPCO: the Syphilis-T CLIA Kit and the Syphilis-NT CLIA Kit. These kits are designed to detect antibodies to Treponema pallidum and non-treponemal lipoidal antigens, respectively, in human serum and plasma using the automated KleeYa platform. The study will collect and analyze blood samples from individuals suspected of having syphilis, those at high risk, HIV-positive patients, pregnant individuals, and healthy controls. The aim is to determine the kits' Positive Percent Agreement (PPA) and Negative Percent Agreement (NPA) compared to established reference assays.

Sponsor: American Laboratory Products Company

Who Can Participate

Inclusion Criteria

Male, Female, or Other(s)
Patients undergoing routine syphilis testing (asymptomatic at risk, suspected with symptoms, prior history of syphilis, high risk for syphilis) or previously diagnosed with syphilis through a test performed in an accredited laboratory.
Participants must be willing to provide the required blood samples for the clinical study, in addition to any samples requested by their physician.
Pregnant individuals and children (under 22): 1 clinical study tube of blood.
All other participants (excluding pregnant individuals and children): 2 clinical study tubes of blood.
Participants must be able and willing to sign the informed consent form (ICF).
Participants aged 13 to 17 will be asked to sign an assent form. Written parental or guardian consent will also be required prior to enrollment. The assent form will use age-appropriate language and be reviewed with the participant before any procedures.

Exclusion Criteria

Patients currently being treated with antibiotics or completed a course of antibiotics within the past 30 days
Patients with pre-existing conditions that would make blood collection difficult or harmful
If the samples are not collected in strict accordance with the established sampling protocol, as determined by the study team.
Any medical, psychological, or social condition that, in the judgment of the investigator, could interfere with the participant's ability to comply with study requirements, or pose a risk to their safety, or compromise the integrity of the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lancaster?

Yes, this clinical trial (NCT07089836) has an active research site in Lancaster, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Treponema Pallidum Treatment Options in Lancaster, CA

If you're searching for treponema pallidum treatment options in Lancaster, CA, this clinical trial (NCT07089836) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lancaster research site is actively enrolling participants for this clinical trial. You'll receive care from experienced treponema pallidum specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all treponema pallidum clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Lancaster, CA

See all leukemia clinical trials recruiting in Lancaster — not just this study.

Browse Leukemia Trials in Lancaster →

Browse More Trials by Condition

Leukemia TrialsAll Conditions →

Ready to Join in Lancaster?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lancaster, CA